Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy
April 05, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., April 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an artificial intelligence (AI)-driven genomic and clinical data intelligence platform company, and researchers from the...
Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
March 14, 2022 16:05 ET
|
Sema4
37% increase in fourth quarter test volumes (excluding COVID-19 tests) compared to the same period last year Record quarterly test volume of nearly 83,000 24% growth in fourth quarter revenue...
Childhood Trauma and Genetics Linked to Increased Obesity Risk
March 09, 2022 13:00 ET
|
Desert Research Institute
Reno, Nev., March 09, 2022 (GLOBE NEWSWIRE) -- New research from the Healthy Nevada Project® found associations between genetics, obesity, and childhood trauma, linking social health determinants,...
Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022
March 08, 2022 08:00 ET
|
Sema4
STAMFORD, Conn., March 08, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, has been named to Fast Company’s prestigious annual...
The Path to Seedless Cannabis: How Triploid Sterile Varieties Can Help Farmers Stop Worrying About Unwanted Pollen
February 24, 2022 17:34 ET
|
Dark Heart Industries
DAVIS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Dark Heart Nursery Executive Speaking Alert. What: Cutting-edge cannabis science content. Richard Philbrook, a leading expert on molecular biology,...
Myriad Genetics Reports Fourth Quarter 2021 Results, Provides Updates on Product Performance and Growth Initiatives
February 24, 2022 09:00 ET
|
Myriad Genetics, Inc.
Highlights: Strong business performance despite COVID-19 headwindsRevenue of $160.8 million in the fourth quarter and $690.6 million for the year ended Dec. 31, 2021, up 4% and 24%, respectively...
SelfDecode Celebrates Black History Month by Addressing the Underrepresentation of African Americans in Genetics Research
February 23, 2022 10:00 ET
|
SelfDecode
MIAMI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- It is a well known problem that African Americans, and other minorities, suffer from a lack of representation within genetic research and databases. This...
Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine
February 22, 2022 08:00 ET
|
Sema4
STAMFORD, Conn. and BOSTON and TORONTO, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, and BioSymetrics, a...
Positive Results for Lipid inCode® in NHS Clinical Study
February 15, 2022 02:00 ET
|
GENinCode Plc
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion...
Sema4 to Participate at Two Upcoming Investor Conferences in February
February 03, 2022 16:05 ET
|
Sema4
STAMFORD, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will...